SCHEMBL16666802

SCHEMBL16666802

[CH2]C(C)[SH](=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21680200 0.72
SCHEMBL22361827 0.72
SCHEMBL13711261 0.70
SCHEMBL18166938 0.70
SCHEMBL20598165 0.67
SCHEMBL25328849 0.65
SCHEMBL6061107 0.64
SCHEMBL29414 0.64
SCHEMBL21963800 0.64
SCHEMBL19259914 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11220503-B2 Phthalazine derivatives, preparation method, pharmaceutical composition and usage thereof SHANGHAI SIMR BIOTECH CO., LTD. (CN) 2022-01-11 US claimed
US-20210330678-A1 PAPD5 INHIBITORS AND METHODS OF USE THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-10-28 US claimed
US-20200165253-A1 Phthalazine Derivatives, Preparation Method, Pharmaceutical Composition and Usage Thereof SHANGHAI SIMRD BIOTECHNOLOGY. CO., LTD. (CN) 2020-05-28 US claimed
US-20190053492-A1 SUBSTITUTED PYRIDINE COMPOUNDS AS PESTICIDES BAYER CROPSCIENCE AG (DE) 2019-02-21 US claimed
CN-101870690-A The prevention and the treatment that are substituted aryl and heteroaryl derivative and associated conditions thereof as metabolism regulators ARENA PHARM INC 2010-10-27 CN claimed
CN-1997640-A Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prevention and treatment of disorders related thereto ARENA PHARM INC (US) 2007-07-11 CN claimed
CN-1153926-A Oximesulfonic acid esters and use thereof as latent sulfonic acids CIBA GEIGY AG (CH) 1997-07-09 CN claimed
US-20240016949-A1 ANTIBODY-DRUG CONJUGATE, AND INTERMEDIATE THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO., LTD. (CN) 2024-01-18 US disclosed
CN-116196411-A PAPD5 and PAPD7 inhibitors for the treatment of hepatitis B infection 豪夫迈·罗氏有限公司 2023-06-02 CN disclosed
CN-113461743-B 6-methylthioethyl purine-2' -deoxynucleoside and preparation method and application thereof 中国石油大学(华东) 2023-03-17 CN disclosed
EP-3212630-B1 NEW DIHYDROQUINOLINE PYRAZOLYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2022-05-18 EP disclosed
US-11220503-B2 Phthalazine derivatives, preparation method, pharmaceutical composition and usage thereof SHANGHAI SIMR BIOTECH CO., LTD. (CN) 2022-01-11 US disclosed
US-20210330678-A1 PAPD5 INHIBITORS AND METHODS OF USE THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-10-28 US disclosed
CN-1253019-A Method for preparing pharmaceutical composition capable of inhibiting postinfectious viral protease ALBERT LAB (US) 2000-05-17 CN disclosed
CN-1052240-C Process for preparing inhibitors of postinfective viral proteases ABBOTT LAB (DE) 2000-05-10 CN disclosed
CN-1212704-A Serine protease inhibitors AKZO NOBEL NV (NL) 1999-03-31 CN disclosed
CN-1212706-A Serine protease inhibitors AKZO NOBEL NV (NL) 1999-03-31 CN disclosed
CN-1207673-A Endoparasiticidal agents BAYER AG (DE) 1999-02-10 CN disclosed
CN-1153926-A Oximesulfonic acid esters and use thereof as latent sulfonic acids CIBA GEIGY AG (CH) 1997-07-09 CN disclosed
CN-1050545-A Inhibitors of post-infective viral proteases HOECHST AG (DE) 1991-04-10 CN disclosed